N-乙酰胞嘧啶结构式
|
常用名 | N-乙酰胞嘧啶 | 英文名 | N-Acetylcytidine |
|---|---|---|---|---|
| CAS号 | 3768-18-1 | 分子量 | 285.253 | |
| 密度 | 1.7±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C11H15N3O6 | 熔点 | 199ºC (dec.) | |
| MSDS | N/A | 闪点 | N/A |
N-乙酰胞嘧啶用途N4-Acetylcytidine 是一种内源性代谢产物。 |
| 中文名 | N-乙酰胞嘧啶核苷 |
|---|---|
| 英文名 | N4-acetylcytidine |
| 中文别名 | N4—乙酰胞嘧啶核苷 | N-乙酰胞嘧啶 |
| 英文别名 | 更多 |
| 密度 | 1.7±0.1 g/cm3 |
|---|---|
| 熔点 | 199ºC (dec.) |
| 分子式 | C11H15N3O6 |
| 分子量 | 285.253 |
| 精确质量 | 285.096100 |
| PSA | 133.91000 |
| LogP | -1.63 |
| InChIKey | NIDVTARKFBZMOT-PEBGCTIMSA-N |
| SMILES | CC(=O)Nc1ccn(C2OC(CO)C(O)C2O)c(=O)n1 |
| 外观性状 | 白色至灰白色结晶粉末 |
| 折射率 | 1.699 |
| 储存条件 | −20°C |
|
~96%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Nahar, Pradip Tetrahedron Letters, 1997 , vol. 38, # 41 p. 7253 - 7254 |
|
~97%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Xu, Yao-Zhong; Zheng, Qinguo; Swann, Peter F. Tetrahedron Letters, 1991 , vol. 32, # 24 p. 2817 - 2820 |
|
~76%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Kuboki, Atsuhito; Ishihara, Takashi; Kobayashi, Eiko; Ohta, Hiromichi; Ishii, Takeshi; Inoue, Ayumu; Mitsuda, Satoshi; Miyazaki, Tatsuo; Kajihara, Yasuhiro; Sugai, Takeshi Bioscience, Biotechnology and Biochemistry, 2000 , vol. 64, # 2 p. 363 - 368 |
|
~93%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Rode, Ambadas B.; Son, Sang Jun; Hong, In Seok Bulletin of the Korean Chemical Society, 2010 , vol. 31, # 7 p. 2061 - 2064 |
|
~89%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Reid, Andrew K.; McHugh, Callum J.; Richie, Graham; Graham, Duncan Tetrahedron Letters, 2006 , vol. 47, # 25 p. 4201 - 4203 |
|
~%
N-乙酰胞嘧啶 3768-18-1 |
| 文献:Chaix, Carole; Molko, Didier; Teoule, Robert Tetrahedron Letters, 1989 , vol. 30, # 1 p. 71 - 74 |
| N-乙酰胞嘧啶上游产品 6 | |
|---|---|
| N-乙酰胞嘧啶下游产品 10 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Exometabolom analysis of breast cancer cell lines: Metabolic signature.
Sci. Rep. 5 , 13374, (2015) Cancer cells show characteristic effects on cellular turnover and DNA/RNA modifications leading to elevated levels of excreted modified nucleosides. We investigated the molecular signature of differen... |
|
|
Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic interaction liquid chromatography.
J. Chromatogr. A. 1403 , 54-62, (2015) The objective of this study was to model the retention of nucleosides and pterins in hydrophilic interaction liquid chromatography (HILIC) via QSRR-based approach. Two home-made (Amino-P-C18, Amino-P-... |
|
|
The pre-mRNA retention and splicing complex controls tRNA maturation by promoting TAN1 expression.
Nucleic Acids Res. 41(11) , 5669-78, (2013) The conserved pre-mRNA retention and splicing (RES) complex, which in yeast consists of Bud13p, Snu17p and Pml1p, is thought to promote nuclear retention of unspliced pre-mRNAs and enhance splicing of... |
|
实验名称:Screen for inhibitors of RMI FANCM (MM2) intereaction
来源:11908
靶标:N/A
External Id:RMI-FANCM-MM2
|
| N-Acetylcytidine |
| N-{1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}acetamide |
| EINECS 223-195-6 |
| MFCD00006540 |
| 4-(Acetylamino)-1-(β-D-ribofuranosyl)pyrimidin-2(1H)-on |
| N4-Acetylcytidine |
| N(4)-acetylcytidine |